
In this interview, Emil Kendziora discusses the future of cryopreservation, longevity science, and the pursuit of life extension. He explains why he views cryostasis as a potential option for individuals facing terminal illness and how advances in medicine could expand future possibilities. Kendziora also shares his journey from practicing medicine to entrepreneurship and outlines his mission to make cryopreservation more accessible, affordable, and scientifically rigorous.
Emil Kendziora is the founder and CEO of Tomorrow.Bio, a cryopreservation company focused on advancing cryostasis and longevity science in Europe. Trained as a medical doctor, he transitioned into entrepreneurship to explore technologies that could extend healthy lifespans and preserve future medical opportunities. Through Tomorrow.Bio, Kendziora works to increase awareness, accessibility, and scientific development within the emerging field of human cryopreservation.
June 12, 2026

Many people think it belongs entirely in science fiction. In reality, preservation is already possible today. The challenge is future revival. We are very transparent about that. Nobody can currently bring a cryopreserved person back, but the goal is to create that possibility through future scientific progress.

I never describe it as a guarantee. Cryopreservation is about improving your odds. If someone chooses burial or cremation, the chance of returning is effectively zero. Cryopreservation offers at least a possibility, and our job is to keep improving those odds through research, governance, and long-term planning.
Use this interview in your research, article, or academic work

Founder & Creative Director at Oner Active
In this interview, Oner Active founder Krissy Cela shares her journey from waitressing and compiling workout PDFs on a student laptop to building a bootstrapped…

Founder & Group CEO at Discovery Group
In this interview, Discovery Group founder and CEO Adrian Gore discusses the behavioral economics behind his shared-value insurance model. Gore outlines the four principles of…

Founder & Executive Chairperson at Biocon
In this interview, Biocon founder and executive chairperson Kiran Mazumdar-Shaw discusses the pioneering of India's biotechnology sector, from launching an enzyme startup to building a…

Co-Founder & CEO at Chapter
In this interview, Chapter co-founder and CEO Cobi Blumenfeld-Gantz discusses the company's rise to a $3 billion valuation in the senior health navigation market. He…

CEO at Oscar Health
In this interview, Oscar Health CEO Mark Bertolini explains how technology, AI, and consumer choice can reshape the health insurance industry. He discusses the future…

Co-Founder at Y Combinator
In this interview, Y Combinator co-founder Paul Graham reflects on twenty-one years of startup acceleration and forty-seven YC batches. Graham explores the nature of founder…